{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:06:32Z","timestamp":1762459592210},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T00:00:00Z","timestamp":1522195200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00467-018-3945-z","type":"journal-article","created":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T20:59:30Z","timestamp":1522270770000},"page":"1263-1267","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: what are the therapeutic options for a better control of phosphatemia?"],"prefix":"10.1007","volume":"33","author":[{"given":"Debora","family":"Claramunt-Taberner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lia","family":"Bertholet-Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Christine","family":"Carlier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Dijoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franck","family":"Chotel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Silve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justine","family":"Bacchetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,28]]},"reference":[{"key":"3945_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.12998\/wjcc.v2.i9.409","volume":"2","author":"I Fathi","year":"2014","unstructured":"Fathi I, Sakr M (2014) Review of tumoral calcinosis: a rare clinico-pathological entity. World J Clin Cases 2:409\u2013414","journal-title":"World J Clin Cases"},{"key":"3945_CR2","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1053\/j.ajkd.2011.08.035","volume":"59","author":"J Bacchetta","year":"2012","unstructured":"Bacchetta J, Salusky IB (2012) Evaluation of hypophosphatemia: lessons from patients with genetic disorders. Am J Kidney Dis 59:152\u2013159","journal-title":"Am J Kidney Dis"},{"key":"3945_CR3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/ng1095-130","volume":"11","author":"F Francis","year":"1995","unstructured":"Francis F, Henning S, Korn B, Reinhardt R, de Jong P, Poustka A, Lehrach H, Rowe PSN, Goulding JN, Summerfield T, Mountford R, Read AP, Popowska E, Pronicka E, Davies KE, O\u2019Riordan JLH, Econs MJ, Nesbitt T, Drezner MK, Oudet C, Pannetier S, Hanauer A, Strom TM, Meindl A, Lorenz B, Cagnoli B, Mohnike KL, Murken J, Meitinger T (1995) A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium. Nat Genet 11:130\u2013136","journal-title":"Nat Genet"},{"key":"3945_CR4","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/81664","volume":"26","author":"ADHR Consortium","year":"2000","unstructured":"ADHR Consortium (2000) Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26:345\u2013348","journal-title":"Nat Genet"},{"key":"3945_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11154-008-9075-3","volume":"9","author":"M Bastepe","year":"2008","unstructured":"Bastepe M, J\u00fcppner H (2008) Inherited hypophosphatemic disorders in children and the evolving mechanisms of phosphate regulation. Rev Endocr Metab Disord 9:171\u2013180","journal-title":"Rev Endocr Metab Disord"},{"key":"3945_CR6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/hmg\/ddi034","volume":"14","author":"A Benet-Pag\u00e8s","year":"2005","unstructured":"Benet-Pag\u00e8s A, Orlik P, Strom TM, Lorenz-Depiereux B (2005) An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet 14:385\u2013390","journal-title":"Hum Mol Genet"},{"key":"3945_CR7","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.berh.2011.10.020","volume":"25","author":"EG Farrow","year":"2011","unstructured":"Farrow EG, Imel EA, White KE (2011) Miscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and \u03b1Klotho). Best Pract Res Clin Rheumatol 25:735\u2013747","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"3945_CR8","doi-asserted-by":"publisher","first-page":"741","DOI":"10.7326\/0003-4819-77-5-741","volume":"77","author":"G Mozaffarian","year":"1972","unstructured":"Mozaffarian G, Lafferty FW, Pearson OH (1972) Treatment of tumoral calcinosis with phosphorus deprivation. Ann Intern Med 77:741\u2013745","journal-title":"Ann Intern Med"},{"key":"3945_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1681\/ASN.2011121191","volume":"24","author":"R Shroff","year":"2013","unstructured":"Shroff R, Long DA, Shanahan C (2013) Mechanistic insights into vascular calcification in CKD. J Am Soc Nephrol 24:179\u2013189","journal-title":"J Am Soc Nephrol"},{"issue":"4suppl","key":"3945_CR10","doi-asserted-by":"publisher","first-page":"247S","DOI":"10.1016\/S8756-3282(95)80001-8","volume":"16","author":"T Yamaguchi","year":"1995","unstructured":"Yamaguchi T, Sugimoto T, Imai Y, Fukase M, Fujita T, Chihara K (1995) Successful treatment of hyperphosphatemic tumoral calcinosis with long-term acetazolamide. Bone 16(4suppl):247S\u2013250S","journal-title":"Bone"},{"key":"3945_CR11","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1002\/jbmr.2870","volume":"31","author":"MS Ramnitz","year":"2016","unstructured":"Ramnitz MS, Gourh P, Goldbach-Mansky R, Wodajo F, Ichikawa S, Econs MJ, White KE, Molinolo A, Chen MY, Heller T, Del Rivero J, Seo-Mayer P, Arabshahi B, Jackson MB, Hatab S, McCarthy E, Guthrie LC, Brillante BA, Gafni RI, Collins MT (2016) Phenotypic and genotypic characterization and treatment of a cohort with familial tumoral calcinosis\/hyperostosis-hyperphosphatemia syndrome. J Bone Miner Res 31:1845\u20131854","journal-title":"J Bone Miner Res"},{"key":"3945_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.bone.2014.06.036","volume":"67","author":"AM Reilly","year":"2014","unstructured":"Reilly AM, Gray AK, Moe SM, Ichikawa S (2014) Nicotinamide treatment in a murine model of familial tumoral calcinosis reduces serum Fgf23 and raises heart calcium. Bone 67:139\u2013144","journal-title":"Bone"},{"key":"3945_CR13","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1002\/jbmr.2242","volume":"29","author":"S Ichikawa","year":"2014","unstructured":"Ichikawa S, Gray AK, Padgett LR, Reilly AM, Unsicker TR (2014) High dietary phosphate intake induces development of ectopic calcifications in a murine model of familial tumoral calcinosis. J Bone Miner Res 29:2017\u20132023","journal-title":"J Bone Miner Res"},{"key":"3945_CR14","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1210\/jc.2016-1087","volume":"101","author":"J Jost","year":"2016","unstructured":"Jost J, Bahans C, Courbebaisse M, Tran T-A, Linglart A, Benistan K, Lienhardt A, Mutar H, Pfender E, Ratsimbazafy V, Guigonis V (2016) Topical sodium thiosulfate: a treatment for calcifications in hyperphosphatemic familial tumoral calcinosis? J Clin Endocrinol Metab 101:2810\u20132815","journal-title":"J Clin Endocrinol Metab"},{"key":"3945_CR15","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jpeds.2010.02.025","volume":"157","author":"M Nguyen","year":"2010","unstructured":"Nguyen M, Boutignon H, Mallet E, Linglart A, Guillozo H, Jehan F, Garabedian M (2010) Infantile hypercalcemia and hypercalciuria: new insights into a vitamin D-dependent mechanism and response to ketoconazole treatment. J Pediatr 157:296\u2013302","journal-title":"J Pediatr"},{"key":"3945_CR16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/ckj\/sfv028","volume":"8","author":"J Sayers","year":"2015","unstructured":"Sayers J, Hynes AM, Srivastava S, Dowen F, Quinton R, Datta HK, Sayer JA (2015) Successful treatment of hypercalcaemia associated with a CYP24A1 mutation with fluconazole. Clin Kidney J 8:453\u2013455","journal-title":"Clin Kidney J"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-018-3945-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-3945-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-3945-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T00:09:07Z","timestamp":1553731747000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-018-3945-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,28]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["3945"],"URL":"https:\/\/doi.org\/10.1007\/s00467-018-3945-z","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,28]]},"assertion":[{"value":"16 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The local ethical committee approved this retrospective case description (Comit\u00e9 de Protection Lyon Sud Est II, IRB approval 00009118, session 20\/04\/2016).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}